Drug Aliquots

Aliquots of Reference Molecules

& Monoclonal Antibody Drugs

Buy as Consumables | Multiple batches are available

Drug aliquots of more than 20 different reference drugs (EU) are available in stock, all of them contain therapeutic monoclonal antibodies as the active ingredient. The drug aliquots are in their clinical use concentration and buffer and, are intended exclusively for use in research and development.

Filters Sort results
Our Products(Reference Drugs as Aliquots)
Antigen
Drug Brand
CoA availability

Adalimumab

drug aliquots
TNF-α
Humira
®
yes

Aflibercept

drug aliquots
VEGF-A
Eylea
®
no

Aldesleukin

drug aliquots
IL-2 RB
Proleukin
®
no

Atezolizumab

drug aliquots
PD-L1
Tecentriq
®
yes

Avelumab

drug aliquots
PD-L1
Bavencio
®
no

Bevacizumab

drug aliquots
VEGF-A
Avastin
®
no
yes

Cetuximab

drug aliquots
EGFR
Erbitux
®
no

Daratumumab

drug aliquots
CD38
Darzalex
®
no

Denosumab

drug aliquots
RANKL
Prolia
®
no

Dinutuximab beta

drug aliquots
GD2
Qarziba
®
no

Durvalumab

drug aliquots
PD-L1
Imfinzi
®
no

Elotuzumab

drug aliquots
SLAM
Empliciti
®
no

Emicizumab

drug aliquots
Clotting Factor IXa and X
Hemlibra
®
no
Erythroid growth factor
Silapo 160000
®
no

Etanercept

drug aliquots
TNF-α
Enbrel
®
no

Golimumab

drug aliquots
TNF-α
Simponi
®
no

Guselkumab

drug aliquots
IL-23
Tremfya
®
no

Infliximab

drug aliquots
TNF-α
Remicade
®
no

Ipilimumab

drug aliquots
CD152
CTLA4
Yervoy
®
yes

Nivolumab

drug aliquots
PD-1
Opdivo
®
no

Obinutuzumab

drug aliquots
CD20
Gazyvaro
®
no

Ocrelizumab

drug aliquots
CD20
Ocrevus(R)
®
no
yes

Palivizumab

drug aliquots
RSV protein F
Synagis
®
yes

Pembrolizumab

drug aliquots
PD-1
Keytruda
®
no
yes

Pertuzumab

drug aliquots
HER2
Perjeta
®
yes

Ramucirumab

drug aliquots
VEGFR2
Cyramza
®
no

Risankizumab

drug aliquots
IL-23
Skyrizi
®
yes

Rituximab

drug aliquots
CD20
Mabthera
®
no
yes

Romiplostim

drug aliquots
Thrombopoietin receptor
NPlate
®
no

Secukinumab

drug aliquots
IL 17A
Cosentyx
®
no

Tocilizumab

drug aliquots
IL-6 R
RoActemra
®
no

Trastuzumab

drug aliquots
HER2
Herceptin
®
no

Ustekinumab

drug aliquots
IL-12
Stelara
®
no
menu_item_coa

Certificate of Analysis (CofA)

for Monoclonal Antibody Drugs

Certificate of Analysis | Original Batch Documentation

Certificate of Analysis (CofA) is an official document issued by the manufacturer of the medicinal product. It contains information on some critical quality characteristics of the medicine. Customers can order the medicinal product CoA together with the drug aliquots of the same batch. A listing of all available CofAs corresponding to the batches of drug aliquots available can be found below.

Filters Sort results
Certificate of Analysis(from reference drug manufacturer)
Batch Number
Expiry Date
Price
CoA – Avastin | Bevacizumab | VEGF-A | B8800H28
B8800H28
03/2021
150,00 
CoA – Humira | Adalimumab | TNF-α | 02006LX02
02006LX02
01/2021
150,00 
CoA – Humira | Adalimumab | TNF-α | 040309A07
040309A07
03/2021
150,00 
CoA – Humira | Adalimumab | TNF-α | 70225XH07
70225XH07
09/2018
150,00 
CoA – Humira | Adalimumab | TNF-α | 73254XH03
73254XH03
12/2018
150,00 
CoA – Humira | Adalimumab | TNF-α | 76287XH07
76287XH07
03/2019
150,00 
CoA – Humira | Adalimumab | TNF-α | 76287XH11
76287XH11
03/2019
150,00 
CoA – Humira | Adalimumab | TNF-α | 80315XH04
80315XH04
07/2019
150,00 
CoA – Humira | Adalimumab | TNF-α | 85364XH07
85364XH07
12/2019
150,00 
CoA – Humira | Adalimumab | TNF-α | 88400XH01
88400XH01
03/2020
150,00 
CoA – Mabthera | Rituximab | CD20 | N7438B09
N7438B09
02/2023
150,00 
CoA – Perjeta | Pertuzumab | HER2 | H0332H02
H0332H02
11/2020
150,00 
CoA – Skyrizi | Risankizumab | IL23 | 1124728
1124728
06/2021
150,00 
CoA – Stelara | Ustekinumab | IL-12 | JKS2Gxx
inquire for details
10/2022
150,00 
CoA – Stelara | Ustekinumab | IL-12 | JKS2Gxy
inquire for details
10/2022
150,00 
CoA – Stelara | Ustekinumab | IL-12 | KCS11xx
inquire for details
02/2023
150,00 
CoA – Synagis | Palivizumab | RSV protein F | 382291
382291
04/2019
150,00 
CoA – Synagis | Palivizumab | RSV protein F | 382445
382445
06/2019
150,00 
CoA – Synagis | Palivizumab | RSV protein F | 382615
382615
10/2019
150,00 
CoA – Synagis | Palivizumab | RSV protein F | 382683
382683
02/2020
150,00 
CoA – Synagis | Palivizumab | RSV protein F | 382835
382835
08/2020
150,00 
CoA – Tecentriq | Atezolizumab | PD-L1 | B0006B01
B0006B01
03/2022
150,00 
CoA – Yervoy | Ipilimumab | CD152 / CTLA4 | ABE0468
ABE0468
08/2021
150,00 

Custom Aliquotation of Reference Drugs

mAb Drugs and mAb-like Drugs

Soon here | Reference Drug Custom Aliquotation

Evidentic provides a unique service for customers in research & development. You can choose from all reference drugs with a EU authorization. Upon your request, we will purchase the drug and generate drug aliqouts.

From inquiry to drug aliquot takes about 3 weeks!

Filters Sort results
1 2 8

You cannot find your drug? We can get it for you!

Showing 1–12 of 74 results